Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.
Beskrivning
Based on recent data concerning the genetic- and geographical diversity of HCV, and increased global disease burden of HCV infection, challenges for global control of HCV infections are described.
Tatsuo Miyamura M.D. PhD. (Jikei University, Japan)Stanley M.Lemon M.D. PhD.(The University of North Carolina, USA) Christopher M. Walker PhD. (The Research Institute at Nationwide Children’s Hospital, USA)Takaji Wakita M.D. PhD. (National Institute of Infectious Diseases, Japan)
Recensioner i media
“This multiauthored book covers a wide array of aspects of infection with hepatitis C, from its natural history to the mechanisms of pathogenicity and the mechanisms of antiviral therapy. … The book is written for a broad audience of scientists, clinicians, and others. Scientists and researchers, as well as trainees with a special interest in hepatitis C, will be best served by this book. … This book does a very nice job of explaining the natural history of hepatitis C.” (Cezarina Mindru, Doody's Book Reviews, February, 2017)
Innehållsförteckning
Part I. Chronic Hepatitis C.- 1. Natural History of chronic hepatitis C (Jake Liang and Marc Ghany).- 2. The Multifaceted Features of HCV Infection beyond the Liver (Kazuhiko Koike).- 3. Hepatic Fibrosis in Hepatitis C (Melissa A. Sheiko and Hugo R. Rosen).- 4. Hepatocellular Carcinoma and Hepatitis C Virus (Sheng-Han Wang, Shiou-Hwei Yeh, and Pei-Jer Chen).- 5. HCV, Alcohol, and the Liver (Terence N. Bukong, Banishree Saha, and Gyongyi Szabo).- 6. Extrahepatic Replication of HCV (Wen-Chi Su, Keigo Machida, and Michael M.C. Lai).- Part II. HCV Infections in Special Populations.- 7. Hepatitis C virus infection in pregnancy and children (Jessica Wen, Samantha Ohmer, Jonathan Honegger).- Part III. Approaches to Therapy.- 8. Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C (Yasuhito Tanaka and Masashi Mizokami).- 9. Viral Variation and Response to Therapy (Shinya Maekawa and Nobuyuki Enomoto).- 10. HCV NS3/4A Protease Inhibitors and the Road to Effective Direct-acting Antiviral Therapies (Nicolas Tremblay, Alex Young Park, and Daniel Lamarre).- 11. Modeling HCV Dynamics in Clinical Practice to Personalize Antiviral Therapy (Piero Colombatto, Ferruccio Bonino, Luigi Civitano, Filippo Oliveri, Gabriele Ricco, Sergio Iannazzo, and Maurizia R. Brunetto).- Part IV. Prevention and Control of HCV Infection.- 12. Prophylactic Vaccines for the Hepatitis C Virus (Andrea L. Cox).- 13. Global control of hepatitis C infection (Tatsuo Miyamura).
